Article · 8 Apr 2026
ArticlePublished 1 Aug 2022
Heterocylcic based curcumin design synthesis and anticancer efficacy against hela cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Developing a new effective anticancer agent becomes an urgent need to overcome of current drug-resistance. In this study, we demonstrated that curcumin with heterocyclic moiety can function as an anticancer agent in a human. A new series of curcumin-based benzodiazepines, diazepines and diazoles were prepared using a simple one pot process. The process involved a condensation reaction of curcumin with various 1,2 diamino compounds and hydrazine. The structures of the prepared heterocycles were identified by the spectroscopic methods Fourier-Transform Infrared Spectroscopy (FT-IR), 1H NMR (Proton Nuclear Magnetic Resonance), and 13C NMR. The in vitro anticancer activities of the synthesized curcumin-based heterocycles against HeLa cancer cells were evaluated by the 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. The viability of HeLa cells was reduced in the range of 4.48%-14.57% within the studied concentrations. Curcumin-based diazepine 6 showed the highest cytotoxic effect on the HeLa cells at all concentrations. It reduced the viability of the tested HeLa cells in range of 4.48% for the 400 μg/ml concentration to 4.95% for the 12.5 μg/ml concentration. Moreover, heterocyclic 6 showed the highest cytotoxic and cytostatic effect among the tested heterocyclics against HeLa cells. It exhibited IC50 (Half-maximal inhibitory concentration) and a cytostatic effect of 0.4572 and 0.08515 μg/ ml, respectively at a nontoxic level, as the control L6 cells showed cytotoxic and cytostatic effect with IC50 values of 22.47 and 1.977 μg/ml, respectively. This study revealed that, the prepared curcumin-based compounds exhibit a promising anticancer activity against HeLa cancer cells at a nontoxic concentration.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Systematic Reviews in Pharmacy.
Article · 30 Sep 2025
AI?IoT Integration: Balancing Innovation and Compliance in Pharmaceutical Manufacturing
Article · 18 Aug 2025
Investigation of microbiological and organoleptic properties of bee products (bee venom, solid pollen, and royal jelly) through water activity quantification during 8 days of storage
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalSystematic Reviews in Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Rana Al-Kerm”
- BylineArticles whose byline prints “Rola Al-Kerm”
- BylineArticles whose byline prints “Othman Hamed”
- BylineArticles whose byline prints “Ashraf Swaft”
- BylineArticles whose byline prints “Mohammad Qneibi”
- BylineArticles whose byline prints “Avni Berisha”
- BylineArticles whose byline prints “Omar Dagdage”
- BylineArticles whose byline prints “Ghaleb Adwan”
